ir.criver.comInvestor Overview | Charles River Laboratories International, Inc.
ir.criver.com Profile
ir.criver.com
Maindomain:criver.com
Title:Investor Overview | Charles River Laboratories International, Inc.
Description：The Investor Relations website contains information about Charles River Laboratories International, Inc.'s business for stockholders, potential investors, and financial analysts.
Discover ir.criver.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.criver.com Information
| Website / Domain: | ir.criver.com |
| HomePage size: | 63.107 KB |
| Page Load Time: | 0.928719 Seconds |
| Website IP Address: | 204.237.221.194 |
| Isp Server: | 7Strategy |
ir.criver.com Ip Information
| Ip Country: | United States |
| City Name: | New York City |
| Latitude: | 40.70813369751 |
| Longitude: | -74.013366699219 |
ir.criver.com Keywords accounting
| Keyword | Count |
|---|
ir.criver.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1589778703" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Mon, 18 May 2020 05:11:43 GMT |
| Link: http://ir.criver.com/; rel="shortlink", https://ir.criver.com/investor-overview/; rel="canonical", https://ir.criver.com/investor-overview; rel="alternate"; hreflang="en", https://ir.criver.com/investor-overview; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 0 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-1054736e-98c6-11ea-9788-138b8f73ddf0 |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 12532 |
| X-EdgeConnect-MidMile-RTT: 51, 51 |
| X-EdgeConnect-Origin-MEX-Latency: 610, 610 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Mon, 18 May 2020 05:11:43 GMT |
| Date: Mon, 18 May 2020 05:11:43 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: SimpleSAMLSessionID=09edfa42df318dc794a1b888786451e0; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
ir.criver.com Meta Info
| charset="utf-8"/ |
| content="Investor Overview | Charles River Laboratories International, Inc." name="title"/ |
| content="Charles River Laboratories International, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about Charles River Laboratories International, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="https://ir.criver.com/investor-overview" property="og:url"/ |
| content="Investor Overview | Charles River Laboratories International, Inc." property="og:title"/ |
| content="The Investor Relations website contains information about Charles River Laboratories International, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
204.237.221.194 Domains
| Domain | WebSite Title |
|---|
ir.criver.com Similar Website
| Domain | WebSite Title |
|---|---|
| Investor Overview | Charles River Laboratories International, Inc. | |
| Charles River Laboratories | Every Step of the Way. | |
| Eureka Blog | Charles River Laboratories. | |
| Charles River Laboratories Completes Acquisition of MPI Research | |
| Choice Hotels International - Investor Relations Home - Investor Relations | |
| Investor Relations | Hill International, Inc. | |
| Investor Relations | ServiceSource International, Inc. | |
| Investor Relations | CAI International | |
| Reading International Investor Center | | |
| Investor Relations | Papa John's International, Inc. | |
| Investor Relations – Power Solutions International, Inc. | |
| Investor Relations | Town Sports International Holdings, Inc. | |
| Investor Relations | Northern Technologies International Corporation | |
| Save The River! Thousand Islands - Clayton NY on the St. Lawrence River - Save The River! is a non-p | |
| Fall River County, South Dakota - 906 N. River Street, Hot Springs, SD 57747 |
ir.criver.com Traffic Sources Chart
ir.criver.com Alexa Rank History Chart
ir.criver.com Html To Plain Text
Skip to main navigation Solutions News & insights Resource Library Events & Training About us Careers Investors Portals Contact Careers Investors Portals Contact Solutions News & insights Resource Library Events & Training About us Investor Relations Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. Investor Overview Investor Overview Webcast Q1 2020 Charles River Laboratories International, Inc. Earnings Conference Call 05/07/20 9:30 AM EDT Q1 2020 Charles River Laboratories International, Inc. Earnings Conference Call 05/07/20 9:30 AM EDT Webcast Presentation Webcast Charles River Laboratories International, Inc. at the Bank of America 2020 Health Care Conference 05/12/20 11:00 AM EDT Charles River Laboratories International, Inc. at the Bank of America 2020 Health Care Conference 05/12/20 11:00 AM EDT Webcast Presentation Corporate Profile Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com . News Releases Date Title and Summary Additional Formats Toggle Summary 05/07/20 Charles River Laboratories Announces First-Quarter 2020 Results – First-Quarter Revenue of $707.1 Million – – First-Quarter GAAP Earnings per Share of $1.02 and Non-GAAP Earnings per Share of $1.84 – – Revises 2020 Guidance Due to COVID-19 Impact – WILMINGTON, Mass. --(BUSINESS WIRE)--May 7, 2020-- Charles River Laboratories International, Inc. View HTML Download PDF 283.4 KB Toggle Summary 04/16/20 Charles River Laboratories Schedules First-Quarter 2020 Earnings Release and Conference Call WILMINGTON, Mass. --(BUSINESS WIRE)--Apr. 16, 2020-- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2020 financial results on Thursday, May 7 th , before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 7 th , View HTML PDF Version Toggle Summary 03/30/20 Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development With Digital Pathology WILMINGTON, Mass. & DUBLIN--(BUSINESS WIRE)--Mar. 30, 2020-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex , a leader in preclinical digital pathology software-as-a-service. View HTML PDF Version Toggle Summary 03/10/20 Charles River Laboratories To Participate In Barclays Global Healthcare Conference WILMINGTON, Mass. --(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will participate in the Barclays Global Healthcare Conference . The Company will present on Wednesday, March 11 th , at 10:15 a.m. ET . View HTML PDF Version View More Upcoming Events There are currently no events scheduled. View More Investor Relations Investor Relations Home Corporate Governance Investor Day 2019 Annual Meeting 2020 Stock Information News Releases Financial Information SEC Filings Presentations Analyst Information Calendar Shareholder Services Stock Quote (common) Price Change (%) Volume Exchange Data as of 04/20/20 1:38 am EDT Copyright West LLC. Minimum 15 minutes delayed. Refresh Quote -- Featured Report 2019 Annual Report (PDF) Toolkit Print Page Email Page RSS Feeds Email Alerts IR Contacts Solutions Products & Services By Research Phase By Therapeutic Area By Industry By Molecule Type News & Insights All Insights Our Blog Featured Stories Media Coverage Resource Library All Resources Forms Product/Service Materials Publications Posters Tools Videos Webinar Archive Libraries Events & Training All Events & Training Seminars & Symposiums Webinars Workshops & Trainings Conferences About Us About Us Overview Our History Our Employees Our Motivation Corporate Social Responsibility Capabilities Animals in Research Eureka Science Community Careers © 2020 Charles River All rights reserved. Legal Privacy Policy Terms & Conditions...
ir.criver.com Whois
"domain_name": "CRIVER.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": "2016-04-13 16:08:23",
"creation_date": "1995-05-08 04:00:00",
"expiration_date": "2021-05-09 04:00:00",
"name_servers": [
"NS-EDI.CHARLESRIVERLABS.NET",
"NS-WLM.CHARLESRIVERLABS.NET"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": "abuse@web.com",
"dnssec": "unsigned",
"name": null,
"org": null,
"address": null,
"city": null,
"state": null,
"zipcode": null,
"country": null